Possible progression of subacute lupus erythematosus--case report
Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematos...
Gespeichert in:
Veröffentlicht in: | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2014-04, Vol.118 (2), p.381-386 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 386 |
---|---|
container_issue | 2 |
container_start_page | 381 |
container_title | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi |
container_volume | 118 |
creator | Brănişteanu, Daciana Elena Lăbonţu, Andreea Ciobanu, Delia Stoleriu, Gabriela Brănişteanu, D Oanţă, A |
description | Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1551020784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551020784</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-4e33c0b642215ded7998e55841f570428f3ab8fafc2776c0054ad0099a4f805e3</originalsourceid><addsrcrecordid>eNo1j8tqwzAURLVoaUKaXyhadiO4lnUteRlCXxBoF-3ayPJVG7AjV49F_r4uTVfDMIdh5oqtAZQR2iizYtuUjj1Ag1oZxBu2kgi60aDWbPcWfsOR-BzDZ6TFhBMPnqfSW1cy8bHMJXGK5_xFk80hlSSEs4l4pDnEfMuuvR0TbS-6YR-PD-_7Z3F4fXrZ7w5irmSThaK6dtA3SsoKBxp02xpCNKryuCyRxte2N956J7VuHAAqOwC0rVXeAFK9Yfd_vcvQ70Ipd9MxORpHe6JQUlchViBhebygdxe09BMN3RyPk43n7v92_QMI8lOC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551020784</pqid></control><display><type>article</type><title>Possible progression of subacute lupus erythematosus--case report</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Brănişteanu, Daciana Elena ; Lăbonţu, Andreea ; Ciobanu, Delia ; Stoleriu, Gabriela ; Brănişteanu, D ; Oanţă, A</creator><creatorcontrib>Brănişteanu, Daciana Elena ; Lăbonţu, Andreea ; Ciobanu, Delia ; Stoleriu, Gabriela ; Brănişteanu, D ; Oanţă, A</creatorcontrib><description>Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.</description><identifier>ISSN: 0048-7848</identifier><identifier>PMID: 25076704</identifier><language>eng</language><publisher>Romania</publisher><subject>Administration, Cutaneous ; Arm - pathology ; Disease Progression ; Drug Therapy, Combination ; Emollients - therapeutic use ; Glucocorticoids - administration & dosage ; Glucocorticoids - therapeutic use ; Humans ; Knee - pathology ; Lip - pathology ; Lupus Erythematosus, Cutaneous - diagnosis ; Lupus Erythematosus, Cutaneous - drug therapy ; Lupus Erythematosus, Cutaneous - pathology ; Male ; Middle Aged ; Mouth Mucosa - pathology ; Nails - pathology ; Skin - pathology ; Treatment Outcome</subject><ispartof>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2014-04, Vol.118 (2), p.381-386</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25076704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brănişteanu, Daciana Elena</creatorcontrib><creatorcontrib>Lăbonţu, Andreea</creatorcontrib><creatorcontrib>Ciobanu, Delia</creatorcontrib><creatorcontrib>Stoleriu, Gabriela</creatorcontrib><creatorcontrib>Brănişteanu, D</creatorcontrib><creatorcontrib>Oanţă, A</creatorcontrib><title>Possible progression of subacute lupus erythematosus--case report</title><title>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi</title><addtitle>Rev Med Chir Soc Med Nat Iasi</addtitle><description>Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.</description><subject>Administration, Cutaneous</subject><subject>Arm - pathology</subject><subject>Disease Progression</subject><subject>Drug Therapy, Combination</subject><subject>Emollients - therapeutic use</subject><subject>Glucocorticoids - administration & dosage</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Knee - pathology</subject><subject>Lip - pathology</subject><subject>Lupus Erythematosus, Cutaneous - diagnosis</subject><subject>Lupus Erythematosus, Cutaneous - drug therapy</subject><subject>Lupus Erythematosus, Cutaneous - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Mucosa - pathology</subject><subject>Nails - pathology</subject><subject>Skin - pathology</subject><subject>Treatment Outcome</subject><issn>0048-7848</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tqwzAURLVoaUKaXyhadiO4lnUteRlCXxBoF-3ayPJVG7AjV49F_r4uTVfDMIdh5oqtAZQR2iizYtuUjj1Ag1oZxBu2kgi60aDWbPcWfsOR-BzDZ6TFhBMPnqfSW1cy8bHMJXGK5_xFk80hlSSEs4l4pDnEfMuuvR0TbS-6YR-PD-_7Z3F4fXrZ7w5irmSThaK6dtA3SsoKBxp02xpCNKryuCyRxte2N956J7VuHAAqOwC0rVXeAFK9Yfd_vcvQ70Ipd9MxORpHe6JQUlchViBhebygdxe09BMN3RyPk43n7v92_QMI8lOC</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Brănişteanu, Daciana Elena</creator><creator>Lăbonţu, Andreea</creator><creator>Ciobanu, Delia</creator><creator>Stoleriu, Gabriela</creator><creator>Brănişteanu, D</creator><creator>Oanţă, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Possible progression of subacute lupus erythematosus--case report</title><author>Brănişteanu, Daciana Elena ; Lăbonţu, Andreea ; Ciobanu, Delia ; Stoleriu, Gabriela ; Brănişteanu, D ; Oanţă, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-4e33c0b642215ded7998e55841f570428f3ab8fafc2776c0054ad0099a4f805e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Cutaneous</topic><topic>Arm - pathology</topic><topic>Disease Progression</topic><topic>Drug Therapy, Combination</topic><topic>Emollients - therapeutic use</topic><topic>Glucocorticoids - administration & dosage</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Knee - pathology</topic><topic>Lip - pathology</topic><topic>Lupus Erythematosus, Cutaneous - diagnosis</topic><topic>Lupus Erythematosus, Cutaneous - drug therapy</topic><topic>Lupus Erythematosus, Cutaneous - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Mucosa - pathology</topic><topic>Nails - pathology</topic><topic>Skin - pathology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brănişteanu, Daciana Elena</creatorcontrib><creatorcontrib>Lăbonţu, Andreea</creatorcontrib><creatorcontrib>Ciobanu, Delia</creatorcontrib><creatorcontrib>Stoleriu, Gabriela</creatorcontrib><creatorcontrib>Brănişteanu, D</creatorcontrib><creatorcontrib>Oanţă, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brănişteanu, Daciana Elena</au><au>Lăbonţu, Andreea</au><au>Ciobanu, Delia</au><au>Stoleriu, Gabriela</au><au>Brănişteanu, D</au><au>Oanţă, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Possible progression of subacute lupus erythematosus--case report</atitle><jtitle>Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi</jtitle><addtitle>Rev Med Chir Soc Med Nat Iasi</addtitle><date>2014-04</date><risdate>2014</risdate><volume>118</volume><issue>2</issue><spage>381</spage><epage>386</epage><pages>381-386</pages><issn>0048-7848</issn><abstract>Subacute lupus erythematosus (SLE) is a specific form of lupus erythematosus characterized by prevalently cutaneous manifestations usually with a good prognosis. It is more common in patients aged 15 to 70 years, and there is a female predilection. This form accounts for 10% of all lupus erythematosus cases. We present the case of a 57-year-old male patient diagnosed at age 35 with chronic psoriasiform subacute lupus erythematosus, pathologically confirmed at the Iaşi Dermatology Clinic. At the age of 54 years he had multiple ischemic strokes, followed by deterioration of general status, and at 56 years deep vein thrombosis in the right leg. The patient presented the erythematous-squamous lesions specific to psoriasiform SLE localized both on the upper third of the body and knees and associated with submucosal lesions of the lower lip, oral mucosa and appendages. The patient also presented hypo- and hyperpigmentated atrophic scar-like lesions. Laboratory tests performed during the last two admissions showed the presence of anti-ds DNA and antiphospholipid antibodies, inflammatory syndrome, and nitrogen retention syndrome. Treatment consisted of systemic and local dermatocorticoids and associated medication, emollient lotions and creams with SPF 50+, with slowly favorable progression. The peculiarity of the case lies in the chronic progression without significant systemic involvement for 19 years, and then in 2 years the antiphospholipid antibody syndrome and a shift to systemic lupus erythematosus to occur.</abstract><cop>Romania</cop><pmid>25076704</pmid><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0048-7848 |
ispartof | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2014-04, Vol.118 (2), p.381-386 |
issn | 0048-7848 |
language | eng |
recordid | cdi_proquest_miscellaneous_1551020784 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Administration, Cutaneous Arm - pathology Disease Progression Drug Therapy, Combination Emollients - therapeutic use Glucocorticoids - administration & dosage Glucocorticoids - therapeutic use Humans Knee - pathology Lip - pathology Lupus Erythematosus, Cutaneous - diagnosis Lupus Erythematosus, Cutaneous - drug therapy Lupus Erythematosus, Cutaneous - pathology Male Middle Aged Mouth Mucosa - pathology Nails - pathology Skin - pathology Treatment Outcome |
title | Possible progression of subacute lupus erythematosus--case report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Possible%20progression%20of%20subacute%20lupus%20erythematosus--case%20report&rft.jtitle=Revista%20medico-chirurgicala%20a%20Societatii%20de%20Medici%20si%20Naturalisti%20din%20Iasi&rft.au=Br%C4%83ni%C5%9Fteanu,%20Daciana%20Elena&rft.date=2014-04&rft.volume=118&rft.issue=2&rft.spage=381&rft.epage=386&rft.pages=381-386&rft.issn=0048-7848&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1551020784%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551020784&rft_id=info:pmid/25076704&rfr_iscdi=true |